Literature DB >> 19849666

Wild-type and missense mutants of retinoschisin co-assemble resulting in either intracellular retention or incorrect assembly of the functionally active octamer.

Lindsay J Gleghorn1, Dorothy Trump, Neil J Bulleid.   

Abstract

The X-linked disease retinoschisis is caused by mutations in the RS1 gene encoding retinoschisin, most commonly missense mutations leading to a lack of secretion of functional protein. One potential approach to treat this disease would be the introduction of the wild-type protein by gene therapy in affected individuals. Retinoschisin normally forms homo-octamers, so co-expression of the wild-type protein with the mutant could result in their co-assembly. In the present study, we show that retinoschisin assembles into an octamer before transport from the endoplasmic reticulum and that co-assembly of wild-type and mutant protein can occur when they are co-expressed in the same cell. This co-assembly results in the retention of some, but not all, expressed wild-type retinoschisin. Moreover, when the wild-type protein is expressed with a missense mutant that is normally secreted, co-assembly occurs resulting in the secretion of a heterogeneous mixture of oligomers. Missense mutations of retinoschisin which cause intracellular retention also lead to an unfolded protein response. However, this is not sufficient to decrease cell viability suggesting that the pathology of the disease is not likely to be linked to programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19849666     DOI: 10.1042/BJ20091179

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

Review 1.  X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms.

Authors:  Robert S Molday; Ulrich Kellner; Bernhard H F Weber
Journal:  Prog Retin Eye Res       Date:  2012-01-03       Impact factor: 21.198

2.  Molecular mechanisms leading to null-protein product from retinoschisin (RS1) signal-sequence mutants in X-linked retinoschisis (XLRS) disease.

Authors:  Camasamudram Vijayasarathy; Ruifang Sui; Yong Zeng; Guoxing Yang; Fei Xu; Rafael C Caruso; Richard A Lewis; Lucia Ziccardi; Paul A Sieving
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

3.  Paired octamer rings of retinoschisin suggest a junctional model for cell-cell adhesion in the retina.

Authors:  Gökhan Tolun; Camasamudram Vijayasarathy; Rick Huang; Yong Zeng; Yan Li; Alasdair C Steven; Paul A Sieving; J Bernard Heymann
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

4.  Recycling of peroxiredoxin IV provides a novel pathway for disulphide formation in the endoplasmic reticulum.

Authors:  Timothy J Tavender; Jennifer J Springate; Neil J Bulleid
Journal:  EMBO J       Date:  2010-11-05       Impact factor: 11.598

5.  An ex vivo gene therapy approach in X-linked retinoschisis.

Authors:  Abu E Bashar; Andrew L Metcalfe; Ishaq A Viringipurampeer; Anat Yanai; Cheryl Y Gregory-Evans; Kevin Gregory-Evans
Journal:  Mol Vis       Date:  2016-06-24       Impact factor: 2.367

6.  Structural analysis of X-linked retinoschisis mutations reveals distinct classes which differentially effect retinoschisin function.

Authors:  Ewan P Ramsay; Richard F Collins; Thomas W Owens; C Alistair Siebert; Richard P O Jones; Tao Wang; Alan M Roseman; Clair Baldock
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

7.  Investigation of Correlations Between Optical Coherence Tomography Biomarkers and Visual Acuity in X-Linked Retinoschisis.

Authors:  Zhanjie Lin; Siwen Zang; Dan Jouma Amadou Maman Lawali; Yu Xiao; Xiaomin Zeng; Honghua Yu; Yijun Hu
Journal:  Front Med (Lausanne)       Date:  2022-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.